Malaguarnera Giulia, Madeddu Roberto, Catania Vito Emanuele, Bertino Gaetano, Morelli Luca, Perrotta Rosario Emanuele, Drago Filippo, Malaguarnera Michele, Latteri Saverio
Research Center "The Great Senescence", University of Catania, Catania, Italy.
Department of Biomedical and Biotechnological Science, University of Catania, Catania, Italy.
Oncotarget. 2018 Jan 2;9(9):8785-8800. doi: 10.18632/oncotarget.23835. eCollection 2018 Feb 2.
Anorectal melanoma is an uncommon and aggressive mucosal melanocytic malignancy. Due to its rarity, the pre-operative diagnosis remains difficult. The first symptoms are non-specific such as anal bleeding, anal mass or pain. Although anorectal melanoma carries a poor prognosis; optimal therapeutics strategies are unclear. Surgical resection remains the mainstay of treatment. The optimal surgical procedure for primary tumours is controversial and can vary from wide local excision or endoscopic mucosal resection (EMR) to an abdomino-perineal resection. A high degree of uncertainly exists regarding the benefit of radiation therapy or chemotherapy. The treatment of advanced melanoma is evolving rapidly with better understanding of the disease biology and immunology. Considerable effort has been devoted to the identification of molecular determinants of response to target therapies and immunotherapy.
肛管黑色素瘤是一种罕见且侵袭性强的黏膜黑色素细胞恶性肿瘤。由于其罕见性,术前诊断仍然困难。首发症状是非特异性的,如肛门出血、肛门肿物或疼痛。尽管肛管黑色素瘤预后较差,但最佳治疗策略尚不清楚。手术切除仍然是主要的治疗方法。原发性肿瘤的最佳手术方式存在争议,范围可从广泛局部切除或内镜黏膜切除术(EMR)到腹会阴联合切除术。关于放疗或化疗的益处存在高度不确定性。随着对疾病生物学和免疫学的更好理解,晚期黑色素瘤的治疗正在迅速发展。人们已经投入了大量精力来确定对靶向治疗和免疫治疗反应的分子决定因素。